Microchip implanted in tumors could reveal best drug in days
NCT ID NCT06204614
First seen May 18, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests a tiny device, small enough to fit in a needle tip, that is implanted into bladder tumors. It releases very small amounts of different cancer drugs directly into the tumor to see which one works best. After about 3 days, the device and a bit of surrounding tissue are removed and studied. The goal is to learn which drugs are most effective for each patient, not to treat the cancer itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.